Tachyarrhythmia-induced Cerebral Sinovenous Thrombosis in a Neonate Without Cardiac Malformation  by Matsuoka, Wakato et al.
Pediatrics and Neonatology (2014) 55, 412e413Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.pediatr -neonatol .comBRIEF COMMUNICATIONTachyarrhythmia-induced Cerebral
Sinovenous Thrombosis in a Neonate
Without Cardiac Malformation
Wakato Matsuoka a, Kenichiro Yamamura a,*, Kiyoshi Uike a,
Hazumu Nagata a, Shouichi Ohga b, Toshiro Hara aa Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
b Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences,
Kyushu University, Fukuoka, JapanReceived Nov 19, 2013; received in revised form Jan 26, 2014; accepted Feb 5, 2014
Available online 28 May 2014Neonatal cerebral sinovenous thrombosis (CSVT) is
becoming increasingly diagnosed because of greater clinical
awareness and improved neuroimaging techniques.1,2
Despite the substantial mortality and morbidity, the etiol-
ogy of pediatric CSVT has not been fully understood.3 We
herein report a case of 13-day-old infant who developed
intractable paroxysmal supraventricular tachycardia, which
was subsequently complicated with CSVT.
A 13-day-old Japanese male was admitted to our affili-
ated hospital because of poor feeding and not doing well
for 2 days. The infant was delivered at term with a birth
weight of 3458 g and full APGAR scores. There was no
cardiomyopathy or prothrombotic disorder in his relatives.
On admission, he presented tachycardia at 300 beats/
minute with hypotension. The electrocardiogram (ECG)
showed narrow QRS tachycardia with following P wave
suggesting the diagnosis of paroxysmal supraventricular
tachycardia (Supplementary Figure 1). Cardioversion
(0.5 J/kg twice) after the intubation allowed restoration of
a sinus rhythm. The patient was then transferred to our
hospital for intensive treatment.* Corresponding author. Department of Pediatrics, Graduate
School of Medical Sciences, Kyushu University, 3-1-1, Maidashi,
Higashi-ku, Fukuoka 812-8582, Japan.
E-mail address: yamamura@pediatr.med.kyushu-u.ac.jp (K.
Yamamura).
http://dx.doi.org/10.1016/j.pedneo.2014.02.003
1875-9572/Copyright ª 2014, Taiwan Pediatric Association. Published bInitial physical examination demonstrated an afebrile and
pale infant. He had a sinus rhythm but presented cold ex-
tremities and prolonged capillary refill time (>3 seconds).
Auscultation revealed a gallop rhythm of the heart. Chest X-
ray examination demonstrated pulmonary congestion and
cardiac dilatation with a cardiothoracic ratio of 61%. The
echocardiogram demonstrated an impaired left ventricular
functionwith ejection fraction at the level of 50%. Laboratory
examinations are as follows: white blood cell count
10.68 109/L; hematocrit 35.7%; platelet count 157 109/L;
creatinine kinase 342 U/L; creatine kinase-MB 71 U/L; lactate
dehydrogenase 601 U/L; C-reactive protein 0.11 mg/dL;
troponin-T 0.154 ng/mL; prothrombin timee
international normalized ratio 1.62; activated partial throm-
boplastin time 40.1 seconds; fibrinogen degradation products
63.1 mg/ml; D-dimer 28.5 mg/mL; and brain natriuretic pep-
tide 3956 pg/mL.
The ECG during tachycardia documented the character-
istics of atrioventricular reentrant tachycardia at 300 beats/
minute. The tachycardia was terminated by the intravenous
rapid infusion of ATP three times. The ECG during sinus
rhythm showed no delta wave, suggesting the possibility of
concealed WPW syndrome. Oral propranolol (1e2 mg/kg/
day) and flecainide (3e6 mg/kg/day) succeeded to prevent
the recurrence of refractory arrhythmia. The echocardio-
gram showed a smooth recovery of the left ventricular
function to the normal level of 63% 2 days after admission.y Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) T1-weighted magnetic resonance imaging. (B) Contrast-enhanced computed tomography of the brain after resto-
ration of sinus rhythm. High signal intensity on T1-weighted magnetic resonance imaging (arrow) and flow disturbance on computed
tomography (white arrow) confirmed the diagnosis of right transverse sinus thrombosis.
Cerebral sinovenosus thrombosis by tachyarrhythmia 413Magnetic resonance imaging (MRI) was performed 9 days
after admission, in order to assess the cerebral damage due
to cardiogenic shock. CSVT was indicated on MRI findings
(Figure 1A). Computed tomography (CT) of the brain
determined a right transverse sinus thrombosis (Figure 1B).
Continuous infusion of fractionated heparin (10e22 unit/
kg/hour, activated partial thromboplastin time 42e50 sec-
onds) was started. Two weeks after the anticoagulant
therapy, CT demonstrated recanalization of the transverse
sinus. There were no laboratory data indicating inherited or
acquired thrombophilic predispositions (on 12 days after
admission): normal plasma activity of protein C 69%, pro-
tein S 58% and antithrombin 91%, and undetectable titer of
anticardiolipin antibody 2 U/mL. The patient received no
additional anticoagulant therapy. CSVT did not recur for 6
months after the first event.
This is the first report of neonatal CSVT as a complication
of paroxysmal supraventricular tachycardia. Perinatal
complications, dehydration, sepsis, meningitis, and inheri-
ted thrombophilias such as antithrombin, protein C, or
protein S deficiency are the major associations with pedi-
atric CSVT.4,5 A recent case series reported that none of the
neonates with CSVT had persistently low activity of protein
C, protein S, or antithrombin, and some of them were
considered to have acquired prothrombotic states.4 This
patient showed no evidence of prothrombotic disorders,
although FD fibrinogen degradation products P and D-dimer
had already been elevated on admission. Pediatric venous
thrombosis occurs at the highest incidence in neonates.
Extremely high brain natriuretic peptide level suggested
the presence of cardiac deterioration due to prolonged
tachycardia. We speculate that the cardiogenic shock led to
the stasis of cerebral sinus venous flow that predisposed the
neonate to developing thrombosis.
No randomized clinical trials have been conducted con-
cerning anticoagulation therapy for neonatal CSVT. Howev-
er, the American College of Chest Physicians recommended
initial anticoagulation except in the presence of significant
hemorrhage.6 The favorable response to the short-termanticoagulant therapy in the present case might corrobo-
rate that CSVT was not associated with inherited coagulop-
athy, but the transient circulatory disturbance.
Because the symptoms of CSVT are nonspecific, and
often subtle or asymptomatic, the diagnosis is delayed and
may be missed altogether. Our patient did not present any
neurological symptom at the diagnosis of CSVT. Intensive
imaging tests including brain echogram, CT, and MRI, and
appropriate anticoagulant therapy should be considered for
the neonates having sustained tachyarrhythmia with car-
diac failure.
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